{"DataElement":{"publicId":"2404880","version":"1","preferredName":"Bladder Cancer Recurrent Disease Classification Stage","preferredDefinition":"a description of standard disease staging to classify the return of symptoms after a period of improvement for tumors composed of atypical neoplastic cells in the urinary bladder that invade other tissues.","longName":"BLAD_CA_REC_CLASS_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2404877","version":"1","preferredName":"Bladder Cancer Recurrent Disease Classification","preferredDefinition":"related to assessment and grouping by category for the return of symptoms after a period of improvement for tumors composed of atypical neoplastic cells in the urinary bladder that invade other tissues.","longName":"BLAD_CA_RECDZ_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206697","version":"1","preferredName":"Bladder Malignant Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C12414:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0087-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2486498","version":"1","preferredName":"Recurrent Disease Classification","preferredDefinition":"the return of a sign, symptom, or disease after a remission.:Classification; the grouping of things into classes or categories.","longName":"C38155:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"160B62A6-8646-2BA2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-06-12","modifiedBy":"ONEDATA","dateModified":"2006-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-129B-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018484","version":"1","preferredName":"Bladder Tumor Pathologic T Stage","preferredDefinition":"the pathologic T (tumor) stage of a bladder tumor, determined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BLAD_TUMOR_P_T_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2559524","version":"1","preferredName":"No evidence of primary tumor","longName":"2559524","preferredDefinition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60966","definition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B591-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-9004-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"TUMOR INVADES SUBEPITHELIAL CONNECTIVE TISSUE","ValueMeaning":{"publicId":"2560341","version":"1","preferredName":"TUMOR INVADES SUBEPITHELIAL CONNECTIVE TISSUE","longName":"2560341","preferredDefinition":"TUMOR INVADES SUBEPITHELIAL CONNECTIVE TISSUE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-9006-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"pT2a","valueDescription":"TUMOR INVADES SUPERFICIAL MUSCLES (INNER HALF)","ValueMeaning":{"publicId":"2560344","version":"1","preferredName":"TUMOR INVADES SUPERFICIAL MUSCLES (INNER HALF)","longName":"2560344","preferredDefinition":"TUMOR INVADES SUPERFICIAL MUSCLES (INNER HALF)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-9008-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"pT2b","valueDescription":"TUMOR INVADES DEEP MUSCLES (OUTER HALF)","ValueMeaning":{"publicId":"2560335","version":"1","preferredName":"TUMOR INVADES DEEP MUSCLES (OUTER HALF)","longName":"2560335","preferredDefinition":"TUMOR INVADES DEEP MUSCLES (OUTER HALF)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8BC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-900A-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"pT3a","valueDescription":"TUMOR INVADES PERIVESICAL TISSUE MICROSCOPICALLY","ValueMeaning":{"publicId":"2560339","version":"1","preferredName":"TUMOR INVADES PERIVESICAL TISSUE MICROSCOPICALLY","longName":"2560339","preferredDefinition":"TUMOR INVADES PERIVESICAL TISSUE MICROSCOPICALLY","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-900C-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"pT3b","valueDescription":"TUMOR INVADES PERIVESICAL TISSUE MACROSCOPICALLY (EXTRAVESICAL MASS)","ValueMeaning":{"publicId":"2560338","version":"1","preferredName":"TUMOR INVADES PERIVESICAL TISSUE MACROSCOPICALLY (EXTRAVESICAL MASS)","longName":"2560338","preferredDefinition":"TUMOR INVADES PERIVESICAL TISSUE MACROSCOPICALLY (EXTRAVESICAL MASS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8BF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA12-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T4","valueDescription":"Inflammatory Breast Carcinoma","ValueMeaning":{"publicId":"2558969","version":"1","preferredName":"Inflammatory Breast Carcinoma","longName":"2558969","preferredDefinition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Inflammatory Carcinoma","conceptCode":"C4001","definition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B366-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA14-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ta","valueDescription":"NONINVASIVE PAPILLARY CARCINOMA","ValueMeaning":{"publicId":"2559578","version":"1","preferredName":"NONINVASIVE PAPILLARY CARCINOMA","longName":"2559578","preferredDefinition":"NONINVASIVE PAPILLARY CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA16-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tis","valueDescription":"CARCINOMA IN SITU: \"FLAT TUMOR\"","ValueMeaning":{"publicId":"2558355","version":"1","preferredName":"CARCINOMA IN SITU: \"FLAT TUMOR\"","longName":"2558355","preferredDefinition":"CARCINOMA IN SITU: \"FLAT TUMOR\"","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B100-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA18-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tx","valueDescription":"PRIMARY TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559890","version":"1","preferredName":"PRIMARY TUMOR CANNOT BE ASSESSED","longName":"2559890","preferredDefinition":"PRIMARY TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA1A-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560359","version":"1","preferredName":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560359","preferredDefinition":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE780675-393D-18EF-E034-0003BA3F9857","beginDate":"2005-08-16","endDate":null,"createdBy":"PWEST","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","deletedIndicator":"No"},{"value":"T3","valueDescription":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560360","version":"1","preferredName":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560360","preferredDefinition":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE780675-393F-18EF-E034-0003BA3F9857","beginDate":"2005-08-16","endDate":null,"createdBy":"PWEST","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Tumor invades the prostate, uterus, vagina ","ValueMeaning":{"publicId":"2576653","version":"1","preferredName":"Tumor invades the prostate, uterus, vagina ","longName":"2576653","preferredDefinition":"Tumor invades the prostate, uterus, vagina ","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A86A42-63B3-70F7-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Tumor invades the pelvic wall, abdominal wall","ValueMeaning":{"publicId":"2576654","version":"1","preferredName":"Tumor invades the pelvic wall, abdominal wall","longName":"2576654","preferredDefinition":"Tumor invades the pelvic wall, abdominal wall","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A86A42-63B7-70F7-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T4","valueDescription":"T4 Stage Finding","ValueMeaning":{"publicId":"3201437","version":"1","preferredName":"T4 Stage Finding","longName":"3201437","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E0D-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B5A0C1-5199-6B38-E053-F662850AB3EC","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","deletedIndicator":"No"},{"value":"T1/Tis","valueDescription":"T1 Stage Finding Tis Stage Finding","ValueMeaning":{"publicId":"6859386","version":"1","preferredName":"T1 Stage Finding Tis Stage Finding","longName":"6859386","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.: A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B5A0C1-51A7-6B38-E053-F662850AB3EC","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B5A0C1-51C0-6B38-E053-F662850AB3EC","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","deletedIndicator":"No"},{"value":"Ta/Tis","valueDescription":"Ta Stage Finding Tis Stage Finding","ValueMeaning":{"publicId":"6859387","version":"1","preferredName":"Ta Stage Finding Tis Stage Finding","longName":"6859387","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.: A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B5A0C1-51CD-6B38-E053-F662850AB3EC","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B5A0C1-51E6-6B38-E053-F662850AB3EC","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47181B6-D3C7-304B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"MORENOC","dateModified":"2019-08-22","changeDescription":"added values for T2 & T3 w/o subcategory","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Stage of Recurrence","url":null,"context":"CTEP"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0097D42F-EE8B-6DB9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-12","modifiedBy":"CAMPBELB","dateModified":"2008-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}